Hepatoblastoma (HB) is the most common liver tumor in the pediatric population, with typically poor outcomes for advanced-stage or chemotherapy-refractory HB patients. The objective of this study was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback